NEW YORK (GenomeWeb News) – Clinical Data’s Cogenics division will provide genotyping services to Tokyo-based drug developer Astellas Pharma, the company said today.
 
Under the agreement, Cogenics will serve as Astellas’ exclusive global provider of biorepository and extraction services and whole-genome association and targeted genotyping services for clinical studies in the US, Europe, and Asia.
 
Cogenics has facilities in North Carolina, Texas, the UK, France, and Germany.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.